Bak N - Search Results

1

Source localization of sensory gating: a combined EEG and fMRI study in healthy volunteers.

Bak N, Glenthoj BY, Rostrup E, Larsson HB, Oranje B. Bak N, et al. Neuroimage. 2011 Feb 14;54(4):2711-8. doi: 10.1016/j.neuroimage.2010.11.039. Epub 2010 Nov 23. Neuroimage. 2011. PMID: 21109008

2

Alterations of the brain reward system in antipsychotic naïve schizophrenia patients.

Nielsen MØ, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S, Glenthøj B. Nielsen MØ, et al. Among authors: bak n. Biol Psychiatry. 2012 May 15;71(10):898-905. doi: 10.1016/j.biopsych.2012.02.007. Epub 2012 Mar 13. Biol Psychiatry. 2012. PMID: 22418013

3

Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia.

Nielsen MO, Rostrup E, Wulff S, Bak N, Broberg BV, Lublin H, Kapur S, Glenthoj B. Nielsen MO, et al. Among authors: bak n. Arch Gen Psychiatry. 2012 Dec;69(12):1195-204. doi: 10.1001/archgenpsychiatry.2012.847. Arch Gen Psychiatry. 2012. PMID: 22868877

4

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia.

Bak N, Rostrup E, Larsson HB, Glenthøj BY, Oranje B. Bak N, et al. Hum Brain Mapp. 2014 Aug;35(8):3578-87. doi: 10.1002/hbm.22422. Epub 2013 Dec 4. Hum Brain Mapp. 2014. PMID: 24375687 Free PMC article.

5

Psychophysiology-informed (multimodal) imaging.

Bak N, Oranje B. Bak N, et al. Curr Top Behav Neurosci. 2014;21:371-85. doi: 10.1007/7854_2014_323. Curr Top Behav Neurosci. 2014. PMID: 24950787

6

Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.

Wulff S, Pinborg LH, Svarer C, Jensen LT, Nielsen MØ, Allerup P, Bak N, Rasmussen H, Frandsen E, Rostrup E, Glenthøj BY. Wulff S, et al. Among authors: bak n. Schizophr Bull. 2015 Sep;41(5):1143-52. doi: 10.1093/schbul/sbu220. Epub 2015 Feb 18. Schizophr Bull. 2015. PMID: 25698711 Free PMC article.

7

Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.

Ishøy PL, Knop FK, Broberg BV, Bak N, Andersen UB, Jørgensen NR, Holst JJ, Glenthøj BY, Ebdrup BH. Ishøy PL, et al. Among authors: bak n. Diabetes Obes Metab. 2017 Feb;19(2):162-171. doi: 10.1111/dom.12795. Epub 2016 Nov 14. Diabetes Obes Metab. 2017. PMID: 27717222 Free PMC article. Clinical Trial.

8

No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia.

Ishøy PL, Fagerlund B, Broberg BV, Bak N, Knop FK, Glenthøj BY, Ebdrup BH. Ishøy PL, et al. Among authors: bak n. Acta Psychiatr Scand. 2017 Jul;136(1):52-62. doi: 10.1111/acps.12711. Epub 2017 Mar 5. Acta Psychiatr Scand. 2017. PMID: 28260235 Clinical Trial.

9

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.

Bak N, Ebdrup BH, Oranje B, Fagerlund B, Jensen MH, Düring SW, Nielsen MØ, Glenthøj BY, Hansen LK. Bak N, et al. Transl Psychiatry. 2017 Apr 11;7(4):e1087. doi: 10.1038/tp.2017.59. Transl Psychiatry. 2017. PMID: 28398342 Free PMC article. Clinical Trial.

10

Testing a decades' old assumption: Are individuals with lower sensory gating indeed more easily distracted?

Bak N, Mann J, Fagerlund B, Glenthøj BY, Jepsen JRM, Oranje B. Bak N, et al. Psychiatry Res. 2017 Sep;255:387-393. doi: 10.1016/j.psychres.2017.05.048. Epub 2017 May 31. Psychiatry Res. 2017. PMID: 28666245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters